CV Sciences (CVSI) Operating Leases (2019 - 2026)

CV Sciences' (CVSI) quarterly Operating Leases came in at $37000.0 in Q1 2026, down 67.83% year-on-year from $115000.0 in Q1 2025, and down 63.0% quarter-over-quarter from $100000.0 in Q4 2025.

CV Sciences (CVSI) Operating Leases (2019 - 2026) Analysis & Trends

CV Sciences has disclosed Operating Leases across 8 years of filings, most recently posting $37000.0 for Q1 2026.

  • Operating Leases for Q1 2026 came in at $37000.0, down 67.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $37000.0 (down 67.83% YoY), and the FY2025 annual result was $100000.0, up 426.32% from the prior year.
  • Operating Leases came in at $37000.0 for Q1 2026 at CV Sciences, down from $100000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $400000.0 in Q2 2022 to a low of $19000.0 in Q4 2024.
  • The 5-year median for Operating Leases is $162000.0 (2025), against an average of $167666.7.
  • Across the five-year window, Operating Leases sank 91.7% in 2024 and surged 426.32% in 2025, its largest moves.
  • CV Sciences' Operating Leases stood at $188000.0 in 2022, then tumbled by 69.15% to $58000.0 in 2023, then slumped by 67.24% to $19000.0 in 2024, then soared by 426.32% to $100000.0 in 2025, then slumped by 63.0% to $37000.0 in 2026.
  • The last three Operating Leases figures came in at $37000.0 (Q1 2026), $100000.0 (Q4 2025), and $162000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn
10 CV Sciences - - 1.56 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 37,000.00
Dec 31, 2025 100,000.00
Sep 30, 2025 162,000.00
Jun 30, 2025 230,000.00
Mar 31, 2025 115,000.00
Dec 31, 2024 19,000.00
Jun 30, 2024 233,000.00
Mar 31, 2024 23,000.00
Dec 31, 2023 58,000.00
Sep 30, 2023 92,000.00
Jun 30, 2023 248,000.00
Mar 31, 2023 277,000.00
Dec 31, 2022 188,000.00
Sep 30, 2022 333,000.00
Jun 30, 2022 400,000.00
Jun 30, 2021 3.11 Mn
Mar 31, 2021 3.29 Mn
Dec 31, 2020 3.47 Mn
Sep 30, 2020 3.64 Mn
Jun 30, 2020 8.83 Mn